Table 3.
Number of patients | 51 |
Responders | 17 (33%) |
Objective response | 14 (27%) |
Stable disease | 3 (6%) |
Non-responders (disease progression) | 34 (67%) |
PgR + status | |
Responders | 15 (88%) |
Non-responders | 23 (68%) |
HER2+ | |
Responders | 7/15 (47%) |
Non-responders | 11/30 (37%) |